Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IV, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Design Study to Determine the Safety and Efficacy of VI-0521 in Obese Adolescents

NCT03922945 is registered in ClinicalTrials.gov with VIVUS LLC as lead sponsor.

NCT NCT03922945
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03922945 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IV, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Design Study to Determine the Safety and Efficacy of VI-0521 in Obese Adolescents
Lead sponsor
VIVUS LLC
Phase
Phase 4
Overall status
Completed
Start date
May 2, 2019
Completion date
April 16, 2021
Enrollment
223 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adolescent obesity, adolescent overweight, obesity in adolescence